Differences in the serum metabolic profile to identify potential biomarkers for cyanotic versus acyanotic heart disease

• Published in: Perfusion 2023-01, Vol.38 (1), p.124-134
• Main Authors: Vimal, Suman, Ranjan, Renuka, Yadav, Surabhi, Majumdar, Gauranga, Mittal, Balraj, Sinha, Neeraj, Agarwal, Surendra Kumar
• Format: Article
• Language: English
• Subjects: Anoxia; Biomarkers; Biomarkers - metabolism; Cardiovascular disease; Cardiovascular diseases; Classification; Congenital diseases; Creatinine; Cyanosis - etiology; Cyanosis - metabolism; Genetic factors; Growth rate; Health services; Heart; Heart Defects, Congenital; Heart diseases; Humans; Hypoxia; Hypoxia - complications; Malnutrition; Mannose; Medical diagnosis; Metabolic disorders; Metabolism; Metabolites; Metabolome; Multivariate statistical analysis; NMR; Nuclear magnetic resonance; Statistical analysis
• ISSN: 0267-6591; 1477-111X
• DOI: 10.1177/02676591211042559

Background: Growth retardation, malnutrition, and failure to thrive are some of the consequences associated with congenital heart diseases. Several metabolic factors such as hypoxia, anoxia, and several genetic factors are believed to alter the energetics of the heart. Timely diagnosis and patient management is one of the major challenges faced by the clinicians in understanding the disease and provide better treatment options. Metabolic profiling has shown to be potential diagnostic tool to understand the disease. Objective: The present experiment was designed as a single center observational pilot study to classify and create diagnostic metabolic signatures associated with the energetics of congenital heart disease in cyanotic and acyanotic groups. Methods: Metabolic sera profiles were obtained from 35 patients with cyanotic congenital heart disease (TOF) and 23 patients with acyanotic congenital heart disease (ASD and VSD) using high resolution 1D 1H NMR spectra. Univariate and multivariate statistical analysis were performed to classify particular metabolic disorders associated with cyanotic and acyanotic heart disease. Results: The results show dysregulations in several metabolites in cyanotic CHD patients versus acyanotic CHD patients. The discriminatory metabolites were further analyzed with area under receiver operating characteristic (AUROC) curve and identified four metabolic entities (i.e. mannose, hydroxyacetone, myoinositol, and creatinine) which could differentiate cyanotic CHDs from acyanotic CHDs with higher specificity. Conclusion: An untargeted metabolic approach proved to be helpful for the detection and distinction of disease-causing metabolites in cyanotic patients from acyanotic ones and can be useful for designing better and personalized treatment protocol.